Introduction
Potassium perchlorate was extensively used as an antithyroid agent in the late 1950s and early 1960s (Crooks and Wayne, 1960) : by competitive inhibition of the trapping of iodide by the thyroid it was effective in reducing thyroid hormone production by the gland, and consequently in relieving symptoms of thyrotoxicosis (Godley and Stanbury, 1954) . No evidence has been produced to suggest that it might influence the natural course of thyrotoxicosis. Following reports of toxicity, in particular of bone marrow hypoplasia (Barzilai and Sheinfeld, 1966) (Connolly, Vidor and Stewart, 1970) .
This patient received potassium perchlorate for 22 years without any untoward effects. The reports of adverse reactions to potassium perchlorate suggested that these effects of the drug were dose related (Morgans and Trotter, 1960) , and it may be that low dose perchlorate (200 mg) is no more toxic than the current generation of thiourylene antithyroid drugs (Barzilai and Sheinfeld, 1966) .
